Roland Leiminger is a trained instrumental analyst, biotechnologist and process engineer. He developed a new process for the purification of electrochemical pollutants in drinking water at the Fraunhofer Institute IPA in Stuttgart and completed his thesis at the TFH Berlin. He then moved into the field of clinical medical diagnostics. Here he carried out technology transfers and established various new diagnostic solutions in the areas of infectiology, first trimester screening and other applications. This also includes sample generation as well as study generation and networking in the sepsis networks. Furthermore, degrees in QM, QB and as a Quality-Auditor were added. By moving into new areas of work, new levels of knowledge and networks were integrated in the area of metabolomic diagnostics using both GC MS/MS and LC MS/MS. Since 2017 he has been responsible for the area of NMR based clinical technical NMR applications in the EIMEA space. Since 2018 he is responsible as Director Key Account Clinical, establishing new NMR IVDr solutions in the field of personalized medicine clinical diagnostics, biobanks, cancer research, rare diseases and personalized medicine. He is vice president of the European, Middle Eastern and African Society for Biobanking and Bio preservation ESBB as well as co-chair of the ESBB working group Automation & Interfaces.
